Tue May 31, 2016 – Reporting by Amrutha Penumudi in Bengaluru StemCells Inc said on Tuesday it had terminated a mid-stage trial testing its therapy in spinal cord injury and that its board had decided to wind down the company. The company’s shares plummeted 75 percent to 75 cents in premarket trading. The magnitude of the treatment’s […]